| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | EcoR1 Capital, LLC | HOOKIPA Pharma Inc. | 4,595,024 | 4.8% | EDGAR |
| SC 13G/A | 2024-02-14 | BAKER BROS. ADVISORS LP | HOOKIPA Pharma Inc. | 8,148,985 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Redmile Group, LLC | HOOKIPA Pharma Inc. | 1,063,769 | 1.1% | EDGAR |
| SC 13G/A | 2023-12-22 | GILEAD SCIENCES, INC. | HOOKIPA Pharma Inc. | 18,759,465 | 19.4% | EDGAR |
| SC 13G/A | 2023-09-11 | FMR LLC | HOOKIPA Pharma Inc. | 3,358,547 | 4.1% | EDGAR |
| SC 13G | 2023-06-20 | Knoll Capital Management, LLC | HOOKIPA Pharma Inc. | 5,517,385 | 6.8% | EDGAR |
| SC 13G/A | 2023-02-14 | EcoR1 Capital, LLC | HOOKIPA Pharma Inc. | 4,973,489 | 9.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Redmile Group, LLC | HOOKIPA Pharma Inc. | 5,460,768 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | GILEAD SCIENCES, INC. | HOOKIPA Pharma Inc. | 3,759,465 | 7.2% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | HOOKIPA Pharma Inc. | 1,240,369 | 2.4% | EDGAR |
| SC 13G | 2023-02-14 | BAKER BROS. ADVISORS LP | HOOKIPA Pharma Inc. | 3,475,535 | 6.6% | EDGAR |
| SC 13D/A | 2023-02-13 | SOFINNOVA CAPITAL VI FCPR | HOOKIPA Pharma Inc. | 3,142,596 | 5.7% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | HOOKIPA Pharma Inc. | 4,895,600 | 9.5% | EDGAR |
| SC 13G/A | 2022-04-11 | FMR LLC | HOOKIPA Pharma Inc. | 5,675,670 | 11.0% | EDGAR |
| SC 13G | 2022-04-08 | EcoR1 Capital, LLC | HOOKIPA Pharma Inc. | 5,090,856 | 10.0% | EDGAR |
| SC 13G | 2022-03-04 | Deep Track Capital, LP | HOOKIPA Pharma Inc. | 5,035,998 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-17 | GILEAD SCIENCES INC | HOOKIPA Pharma Inc. | 3,759,465 | 12.9% | EDGAR |
| SC 13G/A | 2022-02-14 | Redmile Group, LLC | HOOKIPA Pharma Inc. | 2,772,136 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-11 | Forbion Capital Fund II Cooperatief U.A. | HOOKIPA Pharma Inc. | 927 | 3.1% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | HOOKIPA Pharma Inc. | 2,090,200 | 8.0% | EDGAR |